期刊
STEM CELLS
卷 30, 期 8, 页码 1655-1663出版社
WILEY
DOI: 10.1002/stem.1152
关键词
Parkinson's disease; Drug discovery; Neural patterning; Transplantation
资金
- NIH-NINDS [NS045926]
- Parkinson's Disease Foundation, Center for Stem Cells and Regenerative Medicine at the University of Wisconsin Madison
- NICHD [P30 HD03352]
- National Natural Science Foundation of China [30901615]
- NIH-NCRR [P51 RR000167]
By sequentially applying sonic hedgehog (C25II) and CHIR99021 (GSK3 beta inhibitor) to induce the midbrain floor plate (FP) progenitors and fibroblast growth factor 8 (FGF8) to promote dopaminergic differentiation in a chemically defined medium, we have established a robust system for the generation of midbrain dopamine (DA) neurons from human and rhesus monkey embryonic stem cells and induced pluripotent stem cells (PSCs). We found that CHIR99021 specifies diencephalon to hind brain fates in a concentration-dependent manner and only a narrow concentration range of CHIR99021 at a particular window is necessary to induce the midbrain FP progenitors, expressing Corin, En1, FoxA2, and Lmx1a. FGF8 enhances the dopaminergic fate of the progenitors, thus generating DA neurons with midbrain characteristics, including expression of tyrosine hydroxylase, Lmx1a/b, FoxA2, FoxP1, Nurr1, and En1 as well as typical electrophysiological properties. More than half of these DA neurons expressed A9 DA neuron markers Girk2 and ALDH1a1. The new strategy will allow generation of enriched populations of functional midbrain DA neurons from both human and monkey PSCs for disease modeling, drug testing, and potential cell therapy. STEM CELLS 2012;30:1655-1663
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据